Performance of a novel point-of-care molecular assay for detection of influenza A and B viruses and respiratory syncytial virus (enigma minilab) in children with acute respiratory infection

Sam T. Douthwaite, Charlotte Walker, Elisabeth J. Adams, Catherine Mak, Andres Vecino Ortiz, Nuria Martinez-Alier, Simon D. Goldenberg

Research output: Contribution to journalArticlepeer-review

Abstract

The performance of the Enigma MiniLab assay for influenza A and B viruses and respiratory syncytial virus (RSV) was compared to a centralized laboratory respiratory virus panel. The positive and negative percent agreement for influenza A virus, influenza B virus, and RSV were 79.2% (95% confidence interval [95% CI], 57.8 to 92.9%) and 99.4% (95% CI, 98.4 to 99.9), 100% (95% CI, 47.8 to 100%) and 100% (95% CI, 99.3 to 100%), 98.5% (95% CI, 94.6 to 99.8%) and 94.5% (95% CI, 91.9 to 96.4%), respectively.

Original languageEnglish (US)
Pages (from-to)212-215
Number of pages4
JournalJournal of clinical microbiology
Volume54
Issue number1
DOIs
StatePublished - Jan 2016

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Performance of a novel point-of-care molecular assay for detection of influenza A and B viruses and respiratory syncytial virus (enigma minilab) in children with acute respiratory infection'. Together they form a unique fingerprint.

Cite this